Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis

Parasite Immunology

Volumn 35, Issue 3-4, 2013, Pages 103-108

  Hasseldam, H ^a   Hansen, C S ^a   Johansen, F F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Clinical score; Experimental autoimmune encephalomyelitis; Immunological response; Multiple sclerosis; Parasites

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; DISEASE SEVERITY; ENZYME ACTIVATION; HELMINTH; HELMINTHIASIS; IMMUNOMODULATION; IN VITRO STUDY; MULTIPLE SCLEROSIS; NONHUMAN; OBSERVATIONAL STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTOZOAL INFECTION; PROTOZOON; REGULATORY T LYMPHOCYTE; REVIEW; SCHISTOSOMA MANSONI; TRICHURIS SUIS; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

ANIMALS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HELMINTHIASIS; HUMANS; IMMUNE TOLERANCE; MULTIPLE SCLEROSIS; PROTOZOAN INFECTIONS;

EID: 84873444060     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12023     Document Type: Review

References (46)

1. Ramagopalan SV & Sadovnick AD. Epidemiology of multiple sclerosis. Neurol Clin 2011; 29: 207-217.
2. Trapp BD & Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008; 31: 247-269.
3. Burns J, Bartholomew B & Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999; 45: 33-39.
4. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL & Hafler DA. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 1994; 179: 973-984.
5. O'Connor KC, Bar-Or A & Hafler DA. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol 2001; 21: 81-92.
6. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920.
7. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L & Alter M. Epidemiological study of multiple sclerosis in Israel II. Multiple sclerosis and level of sanitation.. J Neurol Neurosurg Psychiatry 1966; 29: 60-68.
8. Fleming JO & Cook TD. Multiple sclerosis and the hygiene hypothesis. Neurology 2006; 67: 2085-2086.
9. Wills-Karp M, Santeliz J & Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001; 1: 69-75.
10. Fallon PG & Mangan NE. Suppression of TH2-type allergic reactions by helminth infection. Nat Rev Immunol 2007; 7: 220-230.
11. Maizels RM, Pearce EJ, Artis D, Yazdanbakhsh M & Wynn TA. Regulation of pathogenesis and immunity in helminth infections. J Exp Med 2009; 206: 2059-2066.
12. McKay DM. The therapeutic helminth? Trends Parasitol 2009; 25: 109-114.
13. Huang SL, Tsai PF & Yeh YF. Negative association of Enterobius infestation with asthma and rhinitis in primary school children in Taipei. Clin Exp Allergy 2002; 32: 1029-1032.
14. Cooper PJ, Chico ME, Rodrigues LC, et al. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J Allergy Clin Immunol 2003; 111: 995-1000.
15. van den Biggelaar AH, van RR, Rodrigues LC, et al. Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet 2000; 356: 1723-1727.
16. Flohr C, Tuyen LN, Lewis S, et al. Poor sanitation and helminth infection protect against skin sensitization in Vietnamese children: a cross-sectional study. J Allergy Clin Immunol 2006; 118: 1305-1311.
17. Leonardi-Bee J, Pritchard D & Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 2006; 174: 514-523.
18. Feary J, Britton J & Leonardi-Bee J. Atopy and current intestinal parasite infection: a systematic review and meta-analysis. Allergy 2011; 66: 569-578.
19. Correale J & Farez M. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007; 61: 97-108.
20. Correale J, Farez M & Razzitte G. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008; 64: 187-199.
21. Correale J & Farez M. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. J Immunol 2009; 183: 5999-6012.
22. Correale J & Farez MF. The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 2011; 233: 6-11.
23. Fleming J, Isaak A, Lee J, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 2011; 17: 743-754.
24. Summers RW, Elliott DE, Urban JF Jr, Thompson R & Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87-90.
25. Summers RW, Elliott DE, Urban JF Jr, Thompson RA & Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825-832.
26. Beer RJ. The relationship between Trichuris trichiura (Linnaeus 1758) of man and Trichuris suis (Schrank 1788) of the pig. Res Vet Sci 1976; 20: 47-54.
27. Gruden-Movsesijan A, Ilic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Milic M & Sofronic-Milosavljevic L. Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunol 2010; 32: 450-459.
28. Chiuso-Minicucci F, Van DB, Zorzella-Pezavento SF, et al. Experimental autoimmune encephalomyelitis evolution was not modified by multiple infections with Strongyloides venezuelensis. Parasite Immunol 2011; 33: 303-308.
29. Sewell D, Qing Z, Reinke E, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003; 15: 59-69.
30. La Flamme AC, Ruddenklau K & Backstrom BT. Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003; 71: 4996-5004.
31. Reyes JL, Espinoza-Jimenez AF, Gonzalez MI, Verdin L & Terrazas LI. Taenia crassiceps infection abrogates experimental autoimmune encephalomyelitis. Cell Immunol 2011; 267: 77-87.
32. Walsh KP, Brady MT, Finlay CM, Boon L & Mills KH. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 2009; 183: 1577-1586.
33. Wu Z, Nagano I, Asano K & Takahashi Y. Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response. Parasitol Res 2010; 107: 1173-1188.
34. Wilson MS, Taylor MD, O'Gorman MT, et al. Helminth-induced CD19 + CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 2010; 40: 1682-1696.
35. Zheng X, Hu X, Zhou G, et al. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J Neuroimmunol 2008; 194: 107-114.
36. Kuijk LM, Klaver EJ, Kooij G, et al. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol 2012; 51: 210-218.
37. Tadokoro CE, Vallochi AL, Rios LS, et al. Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. J Autoimmun 2004; 23: 103-115.
38. Farias AS, Talaisys RL, Blanco YC, et al. Regulatory T cell induction during Plasmodium chabaudi infection modifies the clinical course of experimental autoimmune encephalomyelitis. PLoS ONE 2011; 6: e17849.
39. Wallberg M & Harris RA. Co-infection with Trypanosoma brucei brucei prevents experimental autoimmune encephalomyelitis in DBA/1 mice through induction of suppressor APCs. Int Immunol 2005; 17: 721-728.
40. Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR & Maizels RM. Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 2005; 202: 1199-1212.
41. Taylor MD, van der Werf N, Harris A, et al. Early recruitment of natural CD4 + Foxp3 + Treg cells by infective larvae determines the outcome of filarial infection. Eur J Immunol 2009; 39: 192-206.
42. Gong D, Shi W, Yi SJ, Chen H, Groffen J & Heisterkamp N. TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol 2012; 13: 31.
43. Wan YY & Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol 2008; 28: 647-659.
44. Schnoeller C, Rausch S, Pillai S, et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 2008; 180: 4265-4272.
45. McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY & Harnett W. A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003; 171: 2127-2133.
46. Harnett MM, Kean DE, Boitelle A, et al. The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis 2008; 67: 518-523.